FindHealthNews Index  |  Save/Exchange Information |  WikiWax

    News, Reviews, and Articles on CABG



    Speed Not Always of the Essence with Heart Cases in ER  Nov 13, 2008
    More than 3,000 patients with either a mild heart attack or unstable angina at 100 medical centers in various countries were randomized (after receiving routine therapy) to have a coronary angiography as soon as possible followed by percutaneous coronary intervention (PCI, or widening of the artery) or coronary artery bypass graft (CABG, or bypass surgery) no later than 24 hours after arriving at the hospital or to receive coronary angiography any time after 36 hours followed by PCI or CABG..... (MEDLINEplus)

    Hispanics Less Likely to Get Repeat Artery Surgery  Nov 11, 2008
    SUNDAY, Nov. 9 (HealthDay News) -- Despite certain risk factors, Hispanic patients were 57 percent less likely than Caucasians to undergo coronary artery bypass surgery (CABG) one year after successful angioplasty to open blocked coronary arteries, a new study found ... "With higher rates of insulin-treated diabetes, hypertension and longer lesion lengths, one would expect Hispanic patients to have higher rates of repeat revascularization either through CABG or PCI. However, despite having these... (MEDLINEplus)

    Geisinger Health System's Plan to Fix America's Health Care  Oct 16, 2008
    Says Dr. Ronald Paulus, Geisinger's chief innovation and technology officer: "We had to put our money where our mouth was." Steele decided to start with coronary-artery bypass graft (CABG, pronounced cabbage) surgery because it's a high-volume, high-margin procedure that's well studied and has low mortality and complication rates. "We did this to test whether we could take a very complex system across three hospitals with a huge number of people involved and reliably do something we promised... (FastCompany)

    New data examine stents and bypass surgery in patients with 3VD and LMD  Oct 15, 2008
    The SYNTAX trial, with more than 1,800 participants in 62 European sites and 23 U.S. sites, is designed to determine the best treatment options medicated stent or coronary artery bypass graft (CABG) in patients with complex coronary disease (either left main disease, or three vessel disease). The medicated stent used in the trial was a paclitaxel-eluting stent. (EurekAlert!)

    Heart Bypass Surgery: Deadly Delays  Sep 23, 2008
    23, 2008) Delaying elective coronary artery bypass graft (CABG) surgery may be a significant risk factor for post-operative death ... In British Columbia, Canada, recommended maximum waiting times for CABG surgery are six weeks for semi-urgent cases and twelve weeks for cases that are non-urgent ... Surprisingly, however, until now there have been no direct estimates of the benefits gained from performing CABG surgery in a timely manner. (Science Daily)

    A stitch in time saves lives  Sep 20, 2008
    Many health care systems now use priority wait lists for scheduling elective coronary artery bypass grafting (CABG) surgery, but there have not yet been any direct estimates of reductions in in-hospital mortality rate afforded by ensuring that the operation is performed within recommended time periods ... We used a population-based registry to identify patients with established coronary artery disease who underwent isolated CABG in British Columbia, Canada ... We studied whether postoperative... (BioMed Central)

    Mortality rate after bypass surgery down in Pennsylvania  Sep 19, 2008
    The report also noted that patient readmission rates following CABG surgery have declined from 13. 3 percent in 2000 to 10. (Bizjournals.com)

    Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery  Sep 2, 2008
    and MUNICH, Germany, Sept. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: ) today announced one-year data from its landmark SYNTAX trial comparing percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System to contemporary coronary artery bypass graft (CABG) surgery. The overall results demonstrated no statistically significant differences between PCI and CABG in rates of death or myocardial infarction (MI) ... The SYNTAX... (PR Newswire)

    UPDATE 1-Heart bypasses beat drug stents in  Sep 2, 2008
    1 percent for those undergoing surgery and receiving coronary artery bypass grafting, known as CABG, Patrick Serruys of the Erasmus Medical Center, Rotterdam, told the meeting ... CABG requires open-heart surgery ... Dawkins also noted there was a lower rate of stroke for patients treated with stents as compared with CABG.. (Hemscott)

    Stents versus Bypass Grafting for Left Main Coronary Artery Disease  Jul 24, 2008
    To the Editor: Seung et al. (April 24 issue)1 report that there was no significant difference in rates of death and major cardiovascular events between matched cohorts of patients undergoing coronary-artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) for left main coronary artery disease a finding that contrasts with recently published data. 2 The authors, however, did not consider variables that are significantly and independently associated with in-hospital or 30-day... (New England Journal of Medicine)

    Vytorin misses primary end point in SEAS study  Jul 22, 2008
    The combination was significantly more effective than placebo in reducing the risk of ischemic events, a secondary composite end point of nonfatal MI, coronary artery bypass graft (CABG) surgery, PCI, hospitalization for unstable angina, nonhemorrhagic stroke, and cardiovascular death. Vytorin failed to meet a secondary goal of improving aortic-valve disease events, which included valve-replacement surgery, hospitalization because of heart failure, and cardiovascular mortality. (TheHeart.Org)

    Drug-Releasing Stents Decrease Repeat Cardiac Procedures  Jun 25, 2008
    2 percent, coronary artery bypass graft [CABG]). In the drug-eluting stent era group, 19. (Newsmax)

    Aurora Health Care Top Quality System in Nation in Medicare, Premier Healthcare Alliance Pay-For-Performance Project  Jun 18, 2008
    " About the Hospital Quality Incentive Demonstration project The Hospital Quality Incentive Demonstration is the first national project of its kind, designed to determine if economic incentives to hospitals are effective at improving the quality of inpatient care. Through the project, which was launched in 2003 and extended by CMS for an additional three years, Premier collects a set of more than 30 evidence-based clinical quality measures from over 250 hospitals across the country. The quality... (PR Newswire)

    Allon Completes Dosing in Phase II Cognitive Impairment Trial  May 23, 2008
    VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 23, 2008) - Allon Therapeutics Inc. (TSX: - ) today announced it has completed the randomized portion of its Phase II human clinical trial evaluating the Company's product AL-208 as a treatment for the mild cognitive impairment (MCI) that commonly occurs following coronary artery bypass graft (CABG) surgery ... Gordon McCauley, President and CEO of Allon, said the trial will determine whether a single dose of AL-208 administered to patients prior to... (CCNMatthews Press Releases)

    Two New Appointments at Meditor Pharmaceuticals Ltd.  May 13, 2008
    Schachner will collaborate with recently appointed CEO, Dr. Adrian Harel, in the ongoing Phase II Clinical trial on Hypotension in patients undergoing Cardio Artery Bypass Graft (CABG) patients and in designing future clinical trials. Dr. Adrian Harel joined Meditor in January 2008. (PR Newswire)

    Patients Arriving At Hospitals In Off Hours Get Slower, Less Care  Apr 23, 2008
    After adjusting for baseline characteristics, patients arriving during off hours were 7 percent less likely to undergo primary percutaneous coronary intervention (PCI) and 6 percent less likely to undergo PCI or another type of revascularization called coronary artery bypass graft (CABG) compared with patients arriving during regular hours. "Emergency angioplasty, or PCI, is the preferred procedure after an ST-segment elevation myocardial infarction, which is a heart attack caused by a... (Science Daily)

    Heart Surgery Results Good in Low-Volume Hospitals  Apr 23, 2008
    NEW YORK (Reuters Health) - The rate of in-hospital deaths after coronary artery bypass graft (CABG) surgery has steadily declined since 1997, and the proportion of CABG procedures performed at low-volume institutions has increased, according to a report in the April Archives of Surgery. Previous studies have repeatedly demonstrated that the outcome of CABG procedures is better when performed in hospitals that have a high volume of these surgeries ... However, the patterns observed in the... (MEDLINEplus)

    Robot-assisted minimally-invasive CABG surgery  Apr 8, 2008
    For patients with severe blockages, coronary artery bypass graft surgery (cabg) allows surgeons to remove or re-direct a blood vessel from one part of the body and place it around the obstructed part of the artery, effectively by-passing it, and restoring blood flow to the heart muscle. Minimally invasive, robotically-assisted bypass surgery allows physicians to gain access to the heart with several small incisions, unlike conventional bypass surgery which requires the chest to be opened with a... (EurekAlert!)

    Heart Bypass Surgery Doesn't Cause Mental Decline  Apr 4, 2008
    For many years, assumptions have lingered that Coronary Artery Bypass Surgery Grafting (CABG) produces measurable cognitive impairment, either because of the surgery or use of cardiopulmonary bypass ... Thus, despite improvements in surgical procedures, the weight of evidence across decades of clinical research has continued to suggest that CABG produces some degree of cognitive impairment. (Newsmax)

    Anthem launches program to curtail medical errors  Apr 3, 2008
    Mediastinitis (an infection inside the chest) after coronary artery bypass graft (CABG) surgery; and. Hospital-acquired injuries such as fractures, dislocations, intracranial injuries, crushing injuries and burns. (Denver Business Journal, CO)

    Drug Failed To Reduce Heart Attack Risk After Bypass  Apr 3, 2008
    "Coronary artery bypass graft (CABG) surgery is one of the most important therapeutic options for relieving angina and improving survival and quality of life in patients with multi-vessel coronary artery disease," the Duke University scientists wrote. "It is the most commonly performed cardiac surgical procedure in the world, and, in 2005, more than 250,000 CABG procedures were performed in the United States." ... But CABG surgery can lead to serious complications such as heart attack, recurrent... (MEDLINEplus)

    Angioplasty Proves Reasonable Alternative to Bypass Surgery  Apr 2, 2008
    Current guidelines recommend coronary artery bypass grafting (CABG) over percutaneous coronary intervention unless a previous graft has been performed. And until more studies are conducted, CABG should remain the treatment of choice in these patients, the study authors stressed ... Currently, there is limited long-term data comparing CABG and percutaneous coronary intervention with stents in patients with left main coronary artery disease. (MEDLINEplus)

    Allon Reports 2007 Audited Operating Results and Updates 2008 Plans  Mar 19, 2008
    - Commencement of the randomized stage of the Phase II clinical trial evaluating AL-208 (intravenous) as a treatment for the mild cognitive impairment (MCI) that commonly results from coronary artery bypass graft (CABG) surgery ... - Complete enrolment and dosing, analyze data and release results of a Phase II clinical trial evaluating the safety, tolerability and effect of AL-208 as treatment for MCI resulting from ischemic damage during CABG surgery. (CCNMatthews Press Releases)

    New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)  Mar 5, 2008
    About Plavix(R) Plavix(R) is an antiplatelet agent which prevents platelets from sticking together and forming clots in the arteries and is the only widely available prescription antiplatelet approved to reduce the risk of heart attack and stroke across the entire spectrum of ACS. Plavix(R) is indicated for the reduction of atherothrombotic events in patients with a history of recent MI, recent stroke or established peripheral arterial disease (P.A.D.) Plavix(R) is also indicated for patients... (PR Newswire)

    'Cardiac surgery drug ups death rate'  Feb 22, 2008
    All patients underwent coronary-artery bypass surgery (CABG), and 1181 of them also underwent valve surgery. Patients who received either aminocaproic acid or no therapy did not have high rates of death or poor kidney function seen in the aprotinin group. (India Times, India -- Health/Science)

    Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation  Feb 21, 2008
    PHILADELPHIA, Feb. 20 /PRNewswire/ -- According to Anapol Schwartz () attorney James Ronca (), a New England Journal of Medicine study () (to be released in the February 21, 2008, print edition) confirms that Bayer AG's blood-clotting drug Trasylol(R), used in coronary artery bypass graft (CABG) procedures, causes kidney/renal failure and increases mortality risk ... Pulled by Bayer from the market in November 2007 in response to FDA concerns, Trasylol(R) is administered by an anesthesiologist... (PR Newswire)

    Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death  Feb 21, 2008
    Background Aprotinin (Trasylol) is used to mitigate bleeding during coronary-artery bypass grafting (CABG) ... Methods Using electronic administrative records of the Premier Perspective Comparative Database, we studied hospitalized patients with operating-room charges for the use of aprotinin (33,517 patients) or aminocaproic acid (44,682 patients) on the day CABG was performed ... We tabulated the numbers of patients with a hospital-discharge status of death and performed three types of... (New England Journal of Medicine)

    Learning from Aprotinin — Mandatory Trials of Comparative Efficacyand Safety Needed  Feb 21, 2008
    Aprotinin, a hemostatic agent that inhibits the fibrinolytic enzyme plasmin,1 was approved by the Food and Drug Administration (FDA) in 1993 for reducing blood loss during coronary-artery bypass grafting (CABG). By 2006, aprotinin was prescribed for approximately 200,000 patients undergoing cardiac surgery worldwide. (New England Journal of Medicine)

    60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG  Feb 16, 2008
    Feb. 15 /PRNewswire/ -- Cory Watson Crowder is, P.C. ), has filed lawsuits against Bayer AG on behalf of plaintiffs throughout the United States, who allegedly suffered permanent kidney damage after being given Trasylol(R) -- a Bayer-manufactured drug used to prevent excessive bleeding during coronary artery bypass graft surgery (also called CABG or more commonly bypass). According to CBS News, 60 Minutes will report Sunday night that 22,000 additional lives could have been saved had the FDA... (PR Newswire)

    Coronary Artery Bypass Graft Surgery Promising In 90-Year-Olds  Feb 8, 2008
    7, 2008) Coronary artery bypass graft (CABG) surgery is becoming increasingly common, and appears to be a viable treatment, among individuals in their 90s, according to a study published in the American Journal of Cardiology ... CABG surgery creates new pathways around narrowed and blocked arteries, allowing sufficient delivery of blood, oxygen, and nutrients to the heart ... Our results indicate that nonagenarians who are currently selected for CABG procedures can achieve years of life... (Science Daily)

    Downsized Heart Aids Bypass Surgery  Jan 30, 2008
    the Hopkins team found that by combining so-called coronary artery bypass grafting, known as CABG, with surgical ventricular restoration, or SVR, in patients with advanced heart failure, the likelihood of subsequent heart problems was 24 percent, compared to 55 percent in those undergoing CABG alone ... Conte, an associate professor of surgery at the Johns Hopkins University School of Medicine and its Heart Institute, cautions that not all CABG patients can benefit from SVR and that the... (Science Daily)

    Biopure Announces 2007 Fourth Quarter and Year-End Financial Results  Jan 29, 2008
    This trial, begun in 2006, is a Phase 2 clinical trial in patients undergoing multi-vessel coronary artery bypass graft (CABG) surgery. The objective of this trial is to assess the safety and feasibility of Hemopure in reducing heart damage, as measured by cardiac enzyme elevation, and enhancing tissue preservation during CABG surgery. (PR Newswire)

    Newsweek: The debate isn't over yet  Jan 24, 2008
    One of the studies, the first of its kind, pits drug-eluting stents against coronary artery bypass graft (CABG) operations and finds that the devices are not as effective as the surgery ... "Drug-eluting stents are much less invasive than CABG, so people who didn't want to be cut open and laid up for a long time favored them," says , a health policy analyst at SUNY Albany and the lead researcher on the other new study. (MSNBC -- Health)

    Drug-Eluting Stents vs. CABG  Jan 24, 2008
    Background Numerous studies have compared the outcomes of two competing interventions for multivessel coronary artery disease: coronary-artery bypass grafting (CABG) and coronary stenting ... Methods We identified patients with multivessel disease who received drug-eluting stents or underwent CABG in New York State between October 1, 2003, and December 31, 2004, and we compared adverse outcomes (death, death or myocardial infarction, or repeat revascularization) through December 31, 2005, after... (New England Journal of Medicine)

    Allon Trial Studies Pharmacokinetics of AL-108 & AL-208  Jan 10, 2008
    AL-208 is being evaluated in a Phase II trial as a prevention for the mild cognitive impairment (MCI) resulting from ischemic damage during coronary bypass graft surgery (CABG). Trial results will also indicate AL-208's potential as a treatment for the ischemic damage resulting from stroke. (CCNMatthews Press Releases)

    Statins After Bypass Lower Stroke Risk  Nov 8, 2007
    TUESDAY, Nov. 6 (HealthDay News) -- Treatment with cholesterol-lowering statin drugs after coronary artery bypass graft (CABG) surgery reduces a patient's risk of stroke, U.S. researchers report. The study, from the Cleveland Clinic, included more than 5,200 patients who underwent bypass between early 1993 and late 2005. (MEDLINEplus)

    A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females  Nov 7, 2007
    v. formulation) for the treatment of hypotension associated with cardiac (CABG) surgery. Meditor's patent portfolio provides the company with a strong proprietary position in the U.S. and worldwide. (PR Newswire)

    Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions  Nov 5, 2007
    These procedures, which include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), put patients at a high-risk for therapy-related bleeding complications. REG1 is being developed initially to increase therapeutic flexibility and improve patient outcomes in coronary revascularization procedures. (PR Newswire)

    Canadian Trial Of Heart Surgery Drug Trasylol Halted  Oct 27, 2007
    The trial is called BART, Blood Conservation using Antifibrinolytics: A Randomized Trial in High-Risk Cardiac Surgery Patients, and involves 3000 high risk cardiac patients having either a repeat operation for coronary heart bypass graft (CABG) or an operation to replace an aortic valve, or combined valves or valve/CABG procedures. The drug company said it had issued new guidance to physicians and healthcare providers using Trasylol (aprotinin injection) to treat patients having coronary artery... (Medical News Today)

    Voltaren Gel receives FDA approval as first topical prescription treatment for osteoarthritis pain  Oct 23, 2007
    Voltaren Gel is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. Voltaren Gel should not be used in combination with other oral NSAIDs or aspirin because of the potential for increased adverse effects. (EurekAlert! -- Business News)

    What we doMario Petrou is a cardiac and transplant surgeon  Oct 21, 2007
    This is a coronary artery bypass grafting, also known as CABG (pronounced cabbage) ... Its use for CABG has been shown over the years to provide the best survival benefit ... This can include patients referred for CABG or valve replacement as well as transplant patients. (BBC News -- UK)

    Coronary Artery Revascularization  Sep 24, 2007
    Whether a patient receives percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG) depends on many factors ... With involvement of two or more vessels, CABG is preferred because it already takes enough time to thread just one balloon catheter for PTCA. ... Tortuosity of Vessels: If the artery is straight enough, the cardiologist should be able to maneuver a balloon cathether into it and perform PTCA. Otherwise, CABG is the better option. (Suite101.com)

    Prevention and Treatment of Major Blood Loss  Sep 21, 2007
    We would add that in patients with an acute coronary syndrome who require urgent coronary-artery bypass grafting (CABG), antiplatelet therapy with aspirin, clopidogrel, and a glycoprotein IIb/IIIa antagonist (e. g., tirofiban) should be discontinued before surgery. (New England Journal of Medicine)

    FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)  Sep 13, 2007
    Sept. 12 /PRNewswire/ -- Today, the Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) held a meeting to discuss the risk /benefit profile of Trasylol(R) (aprotinin injection), a Bayer drug used in coronary artery bypass graft (CABG) surgery ... The benefit of Trasylol(R) to patients undergoing primary CABG surgery should be weighed against the risk of anaphylaxis associated with any... (PR Newswire)

    'Broader' Look At Cardiac CTA Images Often Finds Disorders Beyond The Heart  Aug 20, 2007
    Performing cardiac CTA after coronary artery bypass surgery (CABG) can reveal unsuspected and potentially significant findings beyond the heart, according to a recent study conducted by researchers at the University of Maryland School of Medicine, located in Baltimore, MD.. Our interest in this topic developed because we were performing many cardiac CTA examinations, including those for bypass grafting, and we wondered how often we would find unrelated but clinically significant findings in the... (Science Daily)

    Arm Squeezing Before CABG May Help Protect Heart  Aug 19, 2007
    Explain to interested patients that this proof-of-concept study found that restricting blood flow to the arm before CABG surgery may stave off injury to the heart ... In the study of 57 CABG patients, the 27 who received ischemic preconditioning showed significant reductions in levels of troponin T, starting six hours after CABG compared with the 30 controls, reported Derek J. Hausenloy, Ph ... The ischemic preconditioning was applied following anesthesia and before CABG.. (MedPage Today)

    Pay for Performance, Version 2.0?  Aug 9, 2007
    "Old wine in a new bottle." "A financial gamble." "An early glimpse of the next generation of pay for performance." All these appraisals have been applied to Geisinger Health System's new approach to elective coronary-artery bypass grafting (CABG), which has been described with words rarely invoked in health care, such as "promise" and "guarantee." Geisinger, an integrated health care delivery system in northeastern Pennsylvania, promises that 40 key processes will be completed for every patient... (New England Journal of Medicine)

    Researchers To Develop Method For Treating Heart Failure And Depression Simultaneously  Jul 31, 2007
    Since 2004, he and his co-principal study investigator, Charles F. Reynolds III, M.D., UPMC Professor of Geriatric Psychiatry, University of Pittsburgh School of Medicine, and their research team have been recruiting patients from several Pittsburgh-area hospitals, including UPMC Presbyterian and UPMC Passavant, into the first NIH-funded clinical trial titled, "Bypassing the Blues," designed to examine the impact of treating depressive symptoms following coronary artery bypass graft (CABG)... (Science Daily)

    * Taiwan Quick Take  Jul 17, 2007
    At the invitation of the Japanese Association of Cardiovascular Surgery, Far Eastern Memorial Hospital took part in the 9th annual symposium of the Japanese off-pump coronary artery bypass graft (CABG) association in Tokyo via satellite hookup. More than 300 heart doctors took part in the symposium, during which they watched surgeries conducted live in Taiwan and Japan. (Taipei Times, Taiwan -- World)

    Blood Pressure Drop During Bypass Might Impair Thinking  Jun 16, 2007
    Researchers at the Johns Hopkins University School of Medicine in Baltimore studied 15 patients, aged 57 to 81, who were given cognitive tests before and then three to five days after they had coronary artery bypass graft (CABG) surgery. All the patients had a decrease in mean arterial pressure (MAP) during surgery compared with their MAP before surgery. (MEDLINEplus)

    Race-based Differences in Revascularization after MI  Jun 14, 2007
    3% of blacks had either PCI or CABG, but 50 ... 3% of black patients eventually had PCI or CABG compared with 25. (MedPage Today)

    Blacks Less Likely to Get Angioplasty After Heart Attack  Jun 13, 2007
    The most common type of revascularization is coronary artery bypass graft (CABG) ... Less than one-fifth of U.S. acute-care hospitals provide coronary revascularization, and many Medicare beneficiaries are initially admitted to hospitals that don't provide CABG or percutaneous coronary intervention (PCI, formerly known as angioplasty). (Forbes)

    Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks  Jun 5, 2007
    In secondary prevention with early and long-term use, PLAVIX has been shown to decrease the rate of atherothrombotic events (cardiovascular death, MI, ischemic stroke, refractory ischemia) when taken in combination with ASA in patients with ACS without ST segment elevation (unstable angina or non-Q-wave myocardial infarction) including patients who are to be managed medically and those who are to be managed with percutaneous coronary intervention (with or without stent) or coronary artery bypass... (Canada Newswire)

    Cardiome And Astellas Announce Positive Results From ACT 2 Trial  Jun 4, 2007
    The trial evaluated the efficacy and safety of the intravenous formulation of vernakalant hydrochloride ("vernakalant (iv)") for the treatment of patients who developed atrial fibrillation or atrial flutter between 24 hours and 7 days following coronary artery bypass graft (CABG) or valve replacement surgery ... The study was focused on the treatment of patients with atrial fibrillation or atrial flutter occurring after CABG or valve replacement surgery. (Canada Newswire)

    Rheumatoid Illness, Smoking Can Harm Heart's Aorta  May 31, 2007
    "Our method of tissue examination allows the condition to be diagnosed in patients undergoing CABG surgery without increasing the preoperative risk.". The findings indicate the need for further research into an inflammatory process that may increase the risk of dying from a heart attack or aneurysm, the researchers said. (MEDLINEplus)

    New insights into chronic inflammation and atherosclerosis  May 25, 2007
    To shed light on the link between chronic inflammation and atherosclerosis, a team of researchers in Norway and the United States, affiliated with the Cleveland Clinic Foundation and Brigham and Women's Hospital in Boston, focused on the aortas of recent recipients of coronary artery bypass graft (CABG) surgery, comparing biopsy specimens from patients with inflammatory rheumatic disease to those from patients without it ... Aortic samples were obtained during CABG surgery, performed at two... (EurekAlert!)

    Experts debate role of stenting, bypass surgery in left main coronary artery disease  May 12, 2007
    At the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), May 912, 2007, in Orlando, FL, two renowned experts will debate the role of PCI and coronary artery bypass grafting (CABG) for the treatment of patients with left main coronary artery disease ... "It is time to start making comparisons of CABG and DES for disease involving the left main coronary artery.". (EurekAlert!)

    'Tables link' to heart death cut  Apr 24, 2007
    The death rate for coronary artery bypass graft (CABG) patients after public disclosure was significantly lower than it had been before, falling from 2. 4% to 1. (BBC News -- UK)

    Dyax Jumps on Positive Drug News  Apr 14, 2007
    Dyax is also developing an alternative treatment for people undergoing coronary artery bypass graft (CABG) surgery, which is typically used for people who have blocked arteries ... If the company can commercialize DX-88 by 2008 and CABG by 2009, S&P expects Dyax to hit operating profitability by 2010. (BusinessWeek)

    Atrial Fibrillation Risk Reduced After Cardiac Surgery Through Use of Hydrocortisone  Apr 12, 2007
    The incidence of AF has been reported to range between 20 percent and 40 percent after coronary artery bypass graft (CABG) surgery and is even higher after heart valve surgery and combined valve and bypass surgery, according to background information in the article ... The study, conducted at three university hospitals in Finland, included 241 patients without prior AF who were scheduled to undergo CABG surgery, aortic valve replacement, or combined CABG surgery and aortic valve replacement. (Science Daily)

    More Women Surviving Heart Surgery  Apr 12, 2007
    NEW YORK (Reuters Health) - There has been a marked decline in early death after coronary artery bypass surgery (CABG), particularly in women, study results indicate. Nevertheless, women remain at higher risk of early death after CABG than men, owing in part to the smaller size of their coronary arteries ... Researchers evaluated gender differences and trends in 30-day mortality after CABG in all adults who had the procedure between 1991 and 2004 in the province of British Columbia, Canada. (MEDLINEplus)

    Novel Platelet Therapy May Reduce PCI Complications  Apr 5, 2007
    Of the total patient population, 573 underwent PCI (primary cohort) while 75 underwent CABG and 382 received medical management. Patients undergoing PCI (primary cohort) were further randomized to a 0. (Science Daily)

    Critics blast PM's health targets as 'soft'  Apr 5, 2007
    Coronary artery bypass graft (CABG) surgery. Common waiting-times benchmarks, meaning the typical time recommended by medical specialists. (Globe and Mail -- National)

    Trust 'must improve heart surgery'  Mar 28, 2007
    The Healthcare Commission started investigating in November 2005 after it emerged that the number of trust patients who died between April 2002 and March 2005 after their first coronary artery bypass graft (CABG) was more than double the national average - 4 ... The report said: "The cardiothoracic unit had rates of mortality for CABG that were higher than other comparable units and that should have prompted an open and questioning response to make certain that everything was being done to... (Channel 4 News)

    Bone Mineral Loss Seen in Men After Heart Surgery  Mar 22, 2007
    NEW YORK (Reuters Health) - In the year following coronary artery bypass grafting (CABG), bone mineral content declines significantly in men, according to findings published in the American Journal of Cardiology ... Dr. Larry E. Miller, of Virginia Polytechnic Institute and State University, and colleagues evaluated changes in bone mineral and body composition in 26 men, between the ages of 50 and 79 years, who underwent CABG. In each patient, blockages were removed in more than one coronary... (MEDLINEplus)

    Regis Philbin To Undergo Heart Bypass  Mar 14, 2007
    Heart bypass surgery is also called coronary artery bypass graft surgery, or CABG (pronounced "cabbage"). When Philbin announced his upcoming bypass surgery on TV, he said he had hoped to get angioplasty instead of bypass surgery, but he said doctors recommended bypass surgery. (CBS News)

    Heart of Darkness  Mar 14, 2007
    Also of interest to the vice president's people may be the ticklish question of whether heart surgery itself, most notably coronary artery bypass grafting (typically referred to as cabg, or "cabbage," surgery), has a long-term impact on cognitive function ... Such personality changes are extremely common in the short term and may persist indefinitely for some, as the Cleveland Clinic notes in its literature on the subject: "Long-term deficits in mental functioning--such as an inability to... (Ocnus.net)

    Symptoms Of Depression Linked To Early Stages Of Artery Disease  Feb 21, 2007
    (January 25, 2005) -- People with symptoms of clinical depression who undergo coronary artery bypass surgery (CABG) have long been known to be at a higher risk of death, hospital readmissions and cardiac events. But does. (Science Daily)

    West Virginia Ranks Last in Heart Disease  Feb 19, 2007
    He has experienced numerous MI's, chronic CHF, angioplasty (1994), CABG (1998), occluded graft (2001), pacemaker insertion (2004), and cardiac ablation (2005) ... We were told there simply was not enough "healthy" heart tissue left undamaged by the MI's to perform another CABG. His cardiologists suggested he be placed on the heart transplant list in order to give researchers time for new meds, technology, and other treatments to be developed in the future that would assist my husband in living a... (MedPage Today)

    Drug Used In Coronary Artery Bypass Graft Surgery May Increase Risk Of Death  Feb 9, 2007
    and colleagues assessed survival rates at six weeks, six months and annually for five years for 3,876 patients undergoing coronary artery bypass graft (CABG) surgery at 62 medical centers around the world ... "These findings indicate that in addition to the previously reported acute renal and vascular safety concerns, aprotinin use is associated with an increased risk of long-term mortality following CABG surgery. Use of aprotinin among patients undergoing CABG surgery does not appear prudent... (Science Daily)

    Blacks Likely to Get Less Experienced Surgeons  Jan 24, 2007
    Until recently, coronary artery bypass grafting (CABG) was usually performed with a heart-lung machine, which allows the heart to be stopped while the bypass grafts are sewn in place ... Performing CABG "off-pump," while the heart is beating normally, is technically demanding and many surgeons are still gaining experience with the technique ... The new findings are based on a study of 15,313 CABG patients who were entered in the New York State Cardiac Surgery Reporting System, which covers all... (MEDLINEplus)

    Heart surgeon faces criminal charges  Jan 9, 2007
    Q: ``When you say you are doing about 10 CABG procedures a year, are you the attending physician, the guy in the chest doing the sewing and cutting. . (The Miami Herald)

    Lawsuits may get settled  Jan 5, 2007
    An unnecessary CABG should be considered assault with a deadly weapon. I was told I needed a quintuple bypass or I could die in three months. (Fredericksburg Free Lance-Star, VA)

    Transfusions Blamed for Deaths After Bypass  Jan 4, 2007
    Moreover, this may explain in part why women are more likely than men to die after coronary artery bypass grafting (CABG), since women more commonly need transfusions than men do ... "To the best of our knowledge, this is the first study to state that ... transfusions may be the reason why women have a greater post-CABG mortality than men," Dr. Mary A. M. Rogers, from the University of Michigan in Ann Arbor, said in a statement ... In a study of Michigan Medicare beneficiaries, 88 percent of... (MEDLINEplus)


    Back to FindHealthNews Home

[ Terms Of Use | Privacy | About ]
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2006